Common Contracts
3 similar Clinical Trial Agreement contracts
ContractClinical Trial Agreement • December 14th, 2016
Clinical Trial Agreement The Clinical Trial Agreement (“Agreement”) is made by and between: Revmatologický ústav, having a place of business at Na Slupi 450/4, Praha 2 – Nové Město, 128 00 Praha 28, Czech Republic, Identification Number: 00023728, Tax Identification Number: CZ00023728, represented by prof. MUDr. Karel Pavelka, DrSc., Director (the “Institution”), and Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ247 68 651, represented by Mr. Alasdair MacDonald, Managing Director (“Quintiles”), and Archigen Biotech Limited, having a place of business at 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambrigde CB2 0AA, United Kingdom, Identification number: 08997356, Tax identification number: GB193046016[insert number], represented by Hyunhwa Youn, Senior Manager, Clinical Development (“Sponsor”) Each a “Party” a
ContractClinical Trial Agreement • September 23rd, 2016
Clinical Trial Agreement The Clinical Trial Agreement (“Agreement”) is made by and between: Fakultní nemocnice Olomouc, having a place of business at I.P.Pavlova 185/6, 779 00 Olomouc, Czech Republic, Identification number: 000 98 892, Tax identification number CZ00098892, represented by Doc. MUDr. Roman Havlík, Ph.D., director (the “Institution”), and Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 247 68 651, Tax identification number: CZ24768651 (“Quintiles”), and Merck KGaA, having a place of business at Frankfurter Str. 250, Darmstadt, Germany, entered into the B Commercial Registry kept by the Common Court in Darmstadt under number HRB 6164 upon power of attorney represented by Quintiles Czech Republic, s.r.o. (“Sponsor”) Each a “Party” and together the “Parties”. Protocol Number: EMR100070-008 Protocol Title: A Phase III open-label, multicenter tri
ContractClinical Trial Agreement • September 12th, 2016
Clinical Trial Agreement The Clinical Trial Agreement (“Agreement”) is made by and between: Revmatologický ústav, having a place of business at Na Slupi 450/4, 128 50 Praha 2, Czech Republic, Identification Number: 00023728, Tax Identification Number: CZ00023728, represented by prof. MUDr. Karel Pavelka, DrSc., Director (the “Institution”), and Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00 Prague, Czech Republic, Identification number: 24768651, Tax identification number: CZ24768651 (“Quintiles”), and Merck KGaA, having a place of business at Frankfurter Str. 250, Darmstadt, Germany, entered into the B Commercial Registry kept by the Common Court in Darmstadt under number HRB 6164 upon power of attorney represented by Quintiles Czech Republic, s.r.o. (“Sponsor”) Each a “Party” and together the “Parties”. Protocol Number: MS200527-0081 Protocol Title: A Phase IIa Randomized, Double-Blind, Placebo-C
